231 related articles for article (PubMed ID: 22423610)
1. Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: evaluation against the accountability for reasonableness framework.
Mori AT; Kaale EA
Implement Sci; 2012 Mar; 7():18. PubMed ID: 22423610
[TBL] [Abstract][Full Text] [Related]
2. The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
Kangwana BP; Kedenge SV; Noor AM; Alegana VA; Nyandigisi AJ; Pandit J; Fegan GW; Todd JE; Brooker S; Snow RW; Goodman CA
PLoS Med; 2011 May; 8(5):e1000437. PubMed ID: 21655317
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of artemisinin-naphthoquine versus artemether-lumefantrine for the treatment of uncomplicated malaria in Papua New Guinean children.
Moore BR; Davis WA; Clarke PM; Robinson LJ; Laman M; Davis TME
Malar J; 2017 Oct; 16(1):438. PubMed ID: 29084540
[TBL] [Abstract][Full Text] [Related]
4. Access to subsidized artemether-lumefantrine from the private sector among febrile children in rural setting in Kilosa, Tanzania.
Simba D; Kakoko D
Tanzan J Health Res; 2012 Apr; 14(2):89-95. PubMed ID: 26591729
[TBL] [Abstract][Full Text] [Related]
5. Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective.
Alba S; Hetzel MW; Goodman C; Dillip A; Liana J; Mshinda H; Lengeler C
Malar J; 2010 Jun; 9():164. PubMed ID: 20550654
[TBL] [Abstract][Full Text] [Related]
6. A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops.
Cohen JM; Sabot O; Sabot K; Gordon M; Gross I; Bishop D; Odhiambo M; Ipuge Y; Ward L; Mwita A; Goodman C
BMC Health Serv Res; 2010 Jul; 10 Suppl 1(Suppl 1):S6. PubMed ID: 20594372
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of dihydroartemisinin-piperaquine compared with artemether-lumefantrine for treating uncomplicated malaria in children at a district hospital in Tanzania.
Mori AT; Ngalesoni F; Norheim OF; Robberstad B
Malar J; 2014 Sep; 13():363. PubMed ID: 25223864
[TBL] [Abstract][Full Text] [Related]
8. Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
Zurovac D; Ndhlovu M; Sipilanyambe N; Chanda P; Hamer DH; Simon JL; Snow RW
Malar J; 2007 Mar; 6():31. PubMed ID: 17367518
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania.
Kabanywanyi AM; Mwita A; Sumari D; Mandike R; Mugittu K; Abdulla S
Malar J; 2007 Nov; 6():146. PubMed ID: 17996121
[TBL] [Abstract][Full Text] [Related]
10. Decentralized health care priority-setting in Tanzania: evaluating against the accountability for reasonableness framework.
Maluka S; Kamuzora P; San Sebastiån M; Byskov J; Olsen ØE; Shayo E; Ndawi B; Hurtig AK
Soc Sci Med; 2010 Aug; 71(4):751-9. PubMed ID: 20554365
[TBL] [Abstract][Full Text] [Related]
11. Artemisinin-based combinations.
Ashley EA; White NJ
Curr Opin Infect Dis; 2005 Dec; 18(6):531-6. PubMed ID: 16258328
[TBL] [Abstract][Full Text] [Related]
12. Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania.
Mori AT; Norheim OF; Robberstad B
Pharmacoeconomics; 2016 Mar; 34(3):303-14. PubMed ID: 26521172
[TBL] [Abstract][Full Text] [Related]
13. An Economic Evaluation of the Posttreatment Prophylactic Effect of Dihydroartemisinin-Piperaquine Versus Artemether-Lumefantrine for First-Line Treatment of Plasmodium falciparum Malaria Across Different Transmission Settings in Africa.
Pfeil J; Borrmann S; Bassat Q; Mulenga M; Talisuna A; Tozan Y
Am J Trop Med Hyg; 2015 Nov; 93(5):961-6. PubMed ID: 26240155
[TBL] [Abstract][Full Text] [Related]
14. Community response to artemisinin-based combination therapy for childhood malaria: a case study from Dar es Salaam, Tanzania.
Kamat VR; Nyato DJ
Malar J; 2010 Feb; 9():61. PubMed ID: 20187949
[TBL] [Abstract][Full Text] [Related]
15. Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.
Smith N; Obala A; Simiyu C; Menya D; Khwa-Otsyula B; O'Meara WP
Malar J; 2011 Oct; 10():316. PubMed ID: 22029829
[TBL] [Abstract][Full Text] [Related]
16. Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial.
Laman M; Moore BR; Benjamin JM; Yadi G; Bona C; Warrel J; Kattenberg JH; Koleala T; Manning L; Kasian B; Robinson LJ; Sambale N; Lorry L; Karl S; Davis WA; Rosanas-Urgell A; Mueller I; Siba PM; Betuela I; Davis TM
PLoS Med; 2014 Dec; 11(12):e1001773. PubMed ID: 25549086
[TBL] [Abstract][Full Text] [Related]
17. Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
[TBL] [Abstract][Full Text] [Related]
18. Artemisinin-naphthoquine for treating uncomplicated Plasmodium falciparum malaria.
Isba R; Zani B; Gathu M; Sinclair D
Cochrane Database Syst Rev; 2015 Feb; 2015(2):CD011547. PubMed ID: 25702785
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin for treating uncomplicated malaria.
van Eijk AM; Terlouw DJ
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD006688. PubMed ID: 21328286
[TBL] [Abstract][Full Text] [Related]
20. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.
Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S
Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
